Dexcom G7 15-Day Review: Accuracy, Cost, and Wear Time
The Dexcom G7 15-Day is a 15-day real-time cgm continuous glucose monitor with a 8.2% MARD accuracy rating and a GlucoseIntel score of 4.7/5.0. The Dexcom G7 15-Day extends the G7 platform to a 15-day sensor life while maintaining the same 8.2% MARD accuracy and 30-minute warmup. FDA-cleared in late 2024, it reduces sensor changes to twice per month and retains full compatibility with Omnipod 5, Tandem t:slim X2, and Tandem Mobi insulin pumps.
As a prescription CGM, the Dexcom G7 15-Day is FDA-cleared for diabetes management and requires a doctor's order. Insurance coverage is widely available for qualifying patients, bringing the monthly cost to $20–$40 per month. Without insurance, the out-of-pocket cost is $250–$350 per month. Medicare Part B covers the Dexcom G7 15-Day for patients who meet eligibility criteria, including documented insulin use and a valid prescription from their treating physician.
Released in 2025 by Dexcom, Inc. (San Diego, California), the Dexcom G7 15-Day uses electrochemical (glucose oxidase) technology to measure glucose in interstitial fluid. It is factory-calibrated and requires no fingerstick confirmations during use. The warmup period after sensor insertion is 30 minutes, one of the fastest in the CGM market.
Dexcom G7 15-Day
by Dexcom
Key Specifications
| Product | MARD | Wear Time | Type | Rx? | With Insurance | Without Insurance | Medicare | Rating |
|---|---|---|---|---|---|---|---|---|
| Dexcom G7 15-Day | 8.2% | 15 days | Real time CGM | Yes | $20–$40 per month | $250–$350 per month | ✓ | 4.7 |
Sensor Type
Electrochemical (glucose oxidase)
Water Resistance
IP68 — waterproof up to 2.4 meters for 24 hours
Age Approval
2 years and older
Transmitter Life
Integrated into sensor (no separate transmitter)
How Accurate Is the Dexcom G7 15-Day?
The Dexcom G7 15-Day has a Mean Absolute Relative Difference (MARD) of 8.2%, which measures the average percentage error between CGM readings and simultaneous laboratory blood glucose measurements. A lower MARD indicates higher accuracy. For context, the most accurate consumer CGM in 2026 is the FreeStyle Libre 3 Plus at 7.9% MARD, while the industry range spans from 7.9% to approximately 9.2% among FDA-cleared devices.
At 8.2% MARD, the Dexcom G7 15-Day is among the most accurate continuous glucose monitors available. This level of accuracy is sufficient for non-adjunctive use, meaning the device can be used as the sole basis for insulin dosing decisions without requiring confirmatory fingerstick tests. Clinical studies have shown that CGMs with a MARD below 9% produce insulin dosing errors comparable to the inherent variability of fingerstick meters themselves.
Accuracy is highest during stable glucose periods and lowest during rapid rates of change — such as the first 60 to 90 minutes after a high-carbohydrate meal or during intense physical exercise. The physiological lag between interstitial fluid glucose (where the sensor measures) and blood glucose (what a fingerstick shows) is typically 5 to 15 minutes. Learn more about how MARD is calculated and what it means for your daily monitoring on our MARD glossary page.
What Does the Dexcom G7 15-Day Cost?
With insurance, the Dexcom G7 15-Day costs $20–$40 per month. Without insurance, the price is $250–$350 per month. Medicare Part B covers the Dexcom G7 15-Day for qualifying patients with diabetes who use insulin. Medicare copays typically range from $0 to $50 per month depending on the specific plan and supplemental coverage.
The annual cost of the Dexcom G7 15-Day depends on sensor replacement frequency. With a 15-day sensor life, users need approximately 25 sensors per year. The longer sensor life reduces annual replacement costs compared to 7-day and 10-day sensors, which require 52 and 37 sensors per year respectively.
For a complete breakdown of CGM costs across all devices, including manufacturer discount programs and patient assistance options, see our comprehensive CGM cost guide.
Sensor Wear Time: 15 Days
The Dexcom G7 15-Day sensor lasts 15 days before requiring replacement. This 15-day wear time is among the longest for adhesive-patch CGMs, requiring only 25 sensor changes per year. Each sensor change involves removing the old sensor, inserting a new one, and waiting 30 minutes for warmup before glucose data resumes.
The 30-minute warmup is the fastest in the CGM market, minimizing the data gap between sensor changes. This is particularly valuable for patients who depend on continuous glucose data for insulin dosing or overnight monitoring.
App and Data Sharing
The Dexcom G7 15-Day pairs with a dedicated smartphone app that displays real-time glucose values, trend arrows, and historical data. The device supports data sharing with caregivers, family members, and healthcare providers, allowing remote monitoring of glucose levels and alerts. Customizable high and low glucose alerts notify users when blood sugar moves outside their target range, and trend-based notifications provide advance warning of rising or falling glucose.
The Dexcom G7 15-Day is compatible with Omnipod 5, Tandem t:slim X2, Tandem Mobi insulin pumps for automated insulin delivery (closed-loop) systems. When paired with a compatible pump, the CGM continuously feeds glucose data to the pump's algorithm, which automatically adjusts basal insulin delivery to keep glucose in the target range. This integration reduces the manual burden of insulin management and has been shown in clinical trials to increase time in range by 10 to 15 percentage points compared to manual pump therapy.
Pros and Cons
Pros
- 15-day wear time — 50% longer than standard G7
- Same 8.2% MARD accuracy as the 10-day G7
- Fewer sensor changes per month (2 instead of 3)
- Lower annual sensor cost due to fewer replacements
- Full insulin pump compatibility maintained
- 30-minute warmup is the fastest in the prescription CGM category
Cons
- Requires prescription — not available over the counter
- Higher uninsured cost compared to Abbott FreeStyle Libre line
- New product — limited long-term user data compared to G7 10-day
- Adhesive must hold for 15 days — may require overtape for some users
Who Should Use the Dexcom G7 15-Day?
The Dexcom G7 15-Day is best suited for patients with type 1 diabetes, insulin-dependent type 2 diabetes, or any condition requiring tight glucose management with automated insulin delivery. Its integration with Omnipod 5 and Tandem t:slim X2 and Tandem Mobi makes it the CGM of choice for closed-loop pump users. Patients who prioritize fast sensor warmup (30 minutes) and real-time predictive alerts will find the Dexcom G7 15-Day aligns with their clinical needs.
How Does the Dexcom G7 15-Day Compare?
See how the Dexcom G7 15-Day stacks up against competing continuous glucose monitors in our head-to-head comparison guides. Each comparison evaluates accuracy, wear time, cost, features, and which device is better for specific use cases.
Dexcom G7 15-Day
by Dexcom